Attenuation of 3,4-methylenedioxymethamphetamine (MDMA) induced neurotoxicity with the serotonin precursors tryptophan and 5-hydroxytryptophan
Authors:
- 1 January 1994
- journal article
- Published by Elsevier in Life Sciences
- Vol. 55 (15) , 1193-1198
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- 5-HT2 receptor-mediated potentiation of dopamine synthesis and central serotonergic deficitsEuropean Journal of Pharmacology, 1993
- The 5-HT2 receptor antagonist, MDL 28,133A, disrupts the serotonergic-dopaminergic interaction mediating the neurochemical effects of 3,4-methylenedioxymethamphetamineEuropean Journal of Pharmacology, 1992
- Effect of 3,4‐Methylenedioxymethamphetamine on 3,4‐Dihydroxyphenylalanine Accumulation in the Striatum and Nucleus AccumbensJournal of Neurochemistry, 1990
- Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by microdialysisLife Sciences, 1990
- Characterization of [3H]Paroxetine Binding in Rat BrainJournal of Neurochemistry, 1988
- Du Pont Backs Phaseout of CFCsScience, 1988
- In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brainBiochemical Pharmacology, 1987
- Effects of enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slicesEuropean Journal of Pharmacology, 1986
- Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic classJournal of Medicinal Chemistry, 1986
- The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brainEuropean Journal of Pharmacology, 1986